v3.26.3
Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Noncontrolling Interest
Total
Balance at Dec. 31, 2024 $ 692 $ 25,416,451 $ 11,693 $ (8,799,721) $ (6,086) $ 16,623,029
Balance (in Shares) at Dec. 31, 2024 6,923,453          
Accretion of stock option expense 32,880 32,880
Accumulated other comprehensive gain (loss) - short-term investments (69,040) (69,040)
Net income (loss) (1,191,800) (40,262) (1,232,062)
Common shares issued for intangible asset $ 20 247,980 248,000
Common shares issued for intangible asset (in Shares)   200,000          
Balance at Mar. 31, 2025 $ 712 25,697,311 (57,347) (9,991,521) (46,348) 15,602,807
Balance (in Shares) at Mar. 31, 2025 7,123,453          
Balance at Dec. 31, 2024 $ 692 25,416,451 11,693 (8,799,721) (6,086) 16,623,029
Balance (in Shares) at Dec. 31, 2024 6,923,453          
Net income (loss)             (3,197,507)
Balance at Sep. 30, 2025 $ 712 25,761,301 75,454 (11,742,383) (260,931) 13,834,153
Balance (in Shares) at Sep. 30, 2025 7,123,453          
Balance at Mar. 31, 2025 $ 712 25,697,311 (57,347) (9,991,521) (46,348) 15,602,807
Balance (in Shares) at Mar. 31, 2025 7,123,453          
Accretion of stock option expense 30,473 30,473
Accumulated other comprehensive gain (loss) - short-term investments 85,732 85,732
Net income (loss) (749,388) (75,184) (824,572)
Balance at Jun. 30, 2025 $ 712 25,727,784 28,385 (10,740,909) (121,532) 14,894,440
Balance (in Shares) at Jun. 30, 2025 7,123,453          
Accretion of stock option expense 33,517 33,517
Accumulated other comprehensive gain (loss) - short-term investments 47,069 47,069
Net income (loss) (1,001,474) (139,399) (1,140,873)
Balance at Sep. 30, 2025 $ 712 25,761,301 75,454 (11,742,383) (260,931) 13,834,153
Balance (in Shares) at Sep. 30, 2025 7,123,453          
Balance at Dec. 31, 2025 $ 712 25,801,322 26,976 (12,700,304) (387,750) 12,740,956
Balance (in Shares) at Dec. 31, 2025 7,123,453          
Common shares issued for cash, net $ 310 5,315,599 5,315,909
Common shares issued for cash, net (in Shares)   3,096,481          
Accretion of stock option expense 53,866 53,866
Accumulated other comprehensive gain (loss) - short-term investments (385,084) (385,084)
Net income (loss) (2,172,525) (301,721) (2,474,246)
Balance at Mar. 31, 2026 $ 1,022 31,170,787 (358,108) (14,872,829) (689,471) 15,251,401
Balance (in Shares) at Mar. 31, 2026 10,219,934          
Balance at Dec. 31, 2025 $ 712 25,801,322 26,976 (12,700,304) (387,750) 12,740,956
Balance (in Shares) at Dec. 31, 2025 7,123,453          
Net income (loss)             (3,473,483)
Balance at Sep. 30, 2026 $ 1,375 35,431,547 (662,218) (15,561,412) (1,000,125) 18,209,167
Balance (in Shares) at Sep. 30, 2026 13,752,288          
Balance at Mar. 31, 2026 $ 1,022 31,170,787 (358,108) (14,872,829) (689,471) 15,251,401
Balance (in Shares) at Mar. 31, 2026 10,219,934          
Common shares issued for cash, net $ 52 1,003,512 1,003,564
Common shares issued for cash, net (in Shares)   524,700          
Accretion of stock option expense 45,201 45,201
Accumulated other comprehensive gain (loss) - short-term investments 60,355 60,355
Net income (loss) 241,056 (263,289) (22,233)
Balance at Jun. 30, 2026 $ 1,074 32,219,500 (297,753) (14,631,773) (952,760) 16,338,288
Balance (in Shares) at Jun. 30, 2026 10,744,634          
Common shares issued for exercise of pre-funded warrants, net $ 301 3,174,006 3,174,307
Common shares issued for exercise of pre-funded warrants, net (in Shares)   3,007,654          
Accretion of stock option expense 38,041 38,041
Accumulated other comprehensive gain (loss) - short-term investments (364,465) (364,465)
Net income (loss) (929,639) (47,365) (977,004)
Balance at Sep. 30, 2026 $ 1,375 $ 35,431,547 $ (662,218) $ (15,561,412) $ (1,000,125) $ 18,209,167
Balance (in Shares) at Sep. 30, 2026 13,752,288